Member Exclusive

Large-scale iPSC production system aimed at clinical therapy funded by NIH

Allele Biotechnology and Pharmaceuticals (San Diego, CA, USA) has been awarded a Phase I SBIR grant by the NIH’s NHLBI to support the development of a large-scale, clinical-grade induced pluripotent stem cell manufacturing system aimed at producing stem cell-derived cells and tissues for clinical application.

Please sign in or register for FREE

No comments yet.